$1.64
+0.01 (+0.61%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+2,661.6% upside
Low Target
$33.37
Average Target
$45.29
High Target
$67.77
Current Price
$1.64
Current
$1.64
$1.64
Target
$45.29
$45.29
$33.37
$45.29 avg
$67.77
Scenario Analysis
Bear Case
$33.37
1,934.8%
Low target
Base Case
$45.29
+2,661.6%
Avg target
Bull Case
$67.77
+4,032.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.55
-70.5% from high
52-Week Low
$1.03
+59.2% from low
Target vs 52W High
$45.29
+716.0% vs high
Next Earnings Report
Nov 17, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.29
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |